
 Scientific claim: Fibroblast Growth Factor is a ligand which signals through receptor tyrosine kinases. 
 Participant Dynamics: Advocate vs. Skeptic 
 Contextual Arena: The Personal Arena (goal: to resolve a personal, high-stakes matter) 
 Interaction Trigger: A Threat (a potential risk or cost) 
 Dialogue Objective: To Define the Disagreement (map out points of conflict) 
```
Advocate: So, Julie, I've been reading up on the Fibroblast Growth Factor, and it's fascinating. It's a ligand that signals through receptor tyrosine kinases. This could be groundbreaking for your research.

Skeptic: Oh, come on, Alex. You can't just take that at face value. Have you considered the potential risks involved with targeting these pathways? The last thing we need is unforeseen side effects.

Advocate: Of course, but the benefits far outweigh the risks. This pathway could open up new treatments for tissue repair and regenerative medicine. Think of the possibilities!

Skeptic: I get that, but it's not just about possibilities. We need concrete evidence. Remember what happened with the last study when things spiraled out of control?

Advocate: That was different, Julie. This time, the data is solid. Plus, plenty of peer-reviewed articles back this claim. Receptor tyrosine kinases are well-documented mediators of cellular processes.

Skeptic: Peer-reviewed or not, jumping on the bandwagon without thorough vetting is risky. What if this triggers an unanticipated cascade of cellular events?

Advocate: You're right to be cautious, but isn't that the essence of scientific progress? We have to take calculated risks to move forward. Think about the potential impact on patients who desperately need these advancements.

Skeptic: Look, I want to believe this as much as you do, but I can't ignore the potential for harm here. We should focus on a controlled environment before applying this broadly.

Advocate: Agreed, we need to proceed carefully. But let's not dismiss it outright. We should map out the points of contention and address them systematically. That way, we can move forward responsibly.

Skeptic: Alright, Alex. Let's define the areas of disagreement and ensure we have a robust framework for assessing the risks. We owe it to ourselves and those we aim to help.

Advocate: Absolutely. Let's work together on this. We've got a lot to gain if we can get it right.
```